1Department of Physiology and Biophysics, University of Washington, Seattle, WA
2Department of Obstetrics and Gynecology, University of Washington, Seattle, WA
3Department of Pharmacology, University of Washington, Seattle, WA.
Address correspondence to: Susan D. Reed, MD, MPH, Department of Obstetrics and Gynecology, University of Washington, Box 356460, Seattle, WA 98195. E-mail: [email protected]
Received 3 October, 2014
Revised 12 March, 2015
Accepted 12 March, 2015
Funding/support: This research was supported by a grant from the National Institutes of Health (NIH; grant 2 R01 HD049651); a cooperative agreement issued by the National Institute on Aging (NIA) in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Development, the National Center for Complementary and Alternative Medicine, and the Office of Research and Women's Health (grants NIA U01 AG032699 and NIA U01 AG03268); a grant from the NIH National Center for Advancing Translational Research (grant UL1TR000423); and a research pilot award from the Department of Obstetrics and Gynecology at the University of Washington. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH Specialized Cooperative Centers Program in Reproduction and Infertility Research (grant U54-HD28934).
Clinical trial registration: ClinicalTrials.gov NCT02070718.
Financial disclosure/conflicts of interest: S.D.R., C.C., D.K.C., and R.A.S. are holders of international patent application number PCT/US13/72772 entitled “Methods and Compositions for Treating Vasomotor Symptoms.” A.E.O. and L.K.F. declare no competing interests.
